The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 27, 2015
Filed:
Sep. 27, 2013
Masahiko Kuroda, Tokyo, JP;
Masami Tanaka, Fukuoka, JP;
Kosuke Oikawa, Kunitachi, JP;
Takayuki Mizutani, Tokyo, JP;
Masakatsu Takanashi, Isehara, JP;
Seiko Iizuka, Tokyo, JP;
Yoshinori Kosugi, Tokyo, JP;
Kazuma Ohyashiki, Tokyo, JP;
Akihiko Tsuchida, Tokyo, JP;
Masahiko Kuroda, Tokyo, JP;
Masami Tanaka, Fukuoka, JP;
Kosuke Oikawa, Kunitachi, JP;
Takayuki Mizutani, Tokyo, JP;
Masakatsu Takanashi, Isehara, JP;
Seiko Iizuka, Tokyo, JP;
Yoshinori Kosugi, Tokyo, JP;
Kazuma Ohyashiki, Tokyo, JP;
Akihiko Tsuchida, Tokyo, JP;
NEC CORPORATION, Tokyo, JP;
TOKYO MEDICAL UNIVERSITY, Tokyo, JP;
Abstract
The present invention provides a novel cancer marker for evaluating the onset, the preclinical stage, the clinical stage, or the prognosis of a cancer in a subject, and an evaluation method using the same. A cancer marker containing at least one miRNA selected from hsa-miR-92 and hsa-miR-494 is used as a marker for cancers excluding breast cancer. A method for evaluating the possibility of cancers excluding breast cancer includes the step of detecting the expression level of a cancer marker in a biological sample collected from a subject. In this method, the cancer marker contains at least one miRNA selected from hsa-miR-92 and hsa-miR-494.